Free to follow every thread. No paywall, no dead ends.
Psychiatry: the story on HearLore | HearLore
Psychiatry
The word psychiatry was first coined by the German physician Johann Christian Reil in 1808, and it literally means the medical treatment of the soul. This definition, drawn from the ancient Greek word psyche which means both soul and butterfly, established a field that has spent two centuries trying to reconcile the biological reality of the brain with the subjective experience of the mind. The fluttering butterfly appears in the coat of arms of Britain's Royal College of Psychiatrists, a symbol that hints at the dual nature of the profession: it is a branch of medicine devoted to the diagnosis, treatment, and prevention of deleterious mental conditions, yet it remains deeply entangled with questions of identity, freedom, and the human spirit. From the earliest days, psychiatry has stood as an intermediary between the social world and the internal world of those who are mentally ill, studying the operations of different organs and body systems as classified by the patient's subjective experiences and the objective physiology of the patient. This unique position has made psychiatry a field of constant tension, where the medical model of disease meets the narrative of human suffering.
Chains, Asylums, and Moral Treatment
In the late 17th century, privately run asylums for the insane began to proliferate and expand in size, but they functioned primarily as custodial institutions rather than places of healing. The Bethlem Royal Hospital in London, the oldest extant psychiatric hospital in the world, was built in the 13th century and remained a place where patients were warehoused without any real treatment applied. It was not until 1792 that the French doctor Philippe Pinel became the chief physician at the Bicêtre Hospital and initiated a radical shift in thinking. Pinel ordered the removal of chains from patients, allowing them to move freely about the hospital grounds and replacing dark dungeons with sunny, well-ventilated rooms. His student and successor, Jean Esquirol, went on to help establish 10 new mental hospitals that operated on the same principles of moral treatment. In England, the Quaker William Tuke independently championed similar reforms, arguing that mental disorder originated from dysfunction of the material brain and body rather than the internal workings of the mind. By 1838, Sergeant John Adams and Dr. John Conolly introduced the method of dispensing with mechanical restraints into the Hanwell Asylum, the largest in the country. Despite these early victories, the asylums of the 19th century quickly became indistinguishable from custodial institutions again, with hundreds of thousands of patients filling the beds by the early 1900s. The Lunacy Act 1845 in England and the 1842 law in New York state marked important landmarks, changing the status of mentally ill people to patients who required treatment, yet the promise of cure often gave way to the reality of long-term confinement.
Who coined the word psychiatry and when was it first used?
The German physician Johann Christian Reil coined the word psychiatry in 1808. The term literally means the medical treatment of the soul and is derived from the ancient Greek word psyche.
When did Philippe Pinel begin his reforms at Bicêtre Hospital?
French doctor Philippe Pinel became the chief physician at the Bicêtre Hospital in 1792. He initiated a radical shift in thinking by ordering the removal of chains from patients and replacing dark dungeons with sunny, well-ventilated rooms.
What year was the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders published?
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders was published in May 2013. This publication coincided with a statement by then-NIMH director Thomas Insel noting that the manual lacks validity compared to other medical specialties due to the absence of objective laboratory measures.
Who coined the term anti-psychiatry and when did this occur?
Psychiatrist David Cooper coined the term anti-psychiatry in 1967. The movement was later made popular by Thomas Szasz, who characterized the field as a pseudoscience or a form of social control masquerading as medicine.
When did US president John F. Kennedy introduce legislation for Community Mental Health Centers?
US president John F. Kennedy introduced legislation delegating the National Institute of Mental Health to administer Community Mental Health Centers in 1963. The intention was to provide care for the chronically mentally ill, but the focus of the centers shifted to providing psychotherapy for those with acute but less serious mental disorders.
What percentage sensitivity and specificity did the American Psychological Association require for biomarkers in 2018?
The American Psychological Association stated that biomarkers used in diagnosis should have a sensitivity of at least 80% for detecting a particular psychiatric disorder and a specificity of at least 80% for distinguishing this disorder from other psychiatric or medical disorders. The 2018 review concluded that very large studies are needed to evaluate specific biomarkers which were not available.
The modern era of biological psychiatry began to take shape in the 20th century, but it was paved with both miraculous cures and horrific mistakes. In 1952, the discovery of chlorpromazine's effectiveness in treating schizophrenia revolutionized the field, offering the first effective medication for a condition that had previously been untreatable. Just a few years earlier, in 1948, lithium carbonate had been shown to stabilize mood highs and lows in bipolar disorder, establishing the foundation of psychopharmacology. These breakthroughs were built upon the work of Otto Loewi, who identified acetylcholine as the first-known neurotransmitter, proving that different neurotransmitters have different and multiple functions in the regulation of behavior. Yet, this biological revolution was preceded by a dark period of psychosurgery. The frontal lobotomy, commonly called a lobotomy, became a common treatment for severe mental illness, largely disappearing only by the late 1970s. The procedure involved cutting the connections to the prefrontal cortex, often leaving patients in a state of emotional flatness or permanent disability. While the psychoanalytic theory of Sigmund Freud had allowed patients to be treated in private practices instead of warehoused in asylums, the psychoanalytic school of thought became marginalized by the 1970s. Biological psychiatry reemerged, and the field began to focus on neurochemistry and the discovery of biomarkers, though the promise of objective diagnosis remained elusive.
The Diagnostic Manual and the Validity Crisis
The Diagnostic and Statistical Manual of Mental Disorders, known as the DSM, has been the primary classification tool in the United States since its first edition, but its fifth edition, published in May 2013, coincided with a statement by then-NIMH director Thomas Insel noting that the manual lacks validity compared to other medical specialties due to the absence of objective laboratory measures. The DSM has attracted both praise for standardizing psychiatric diagnostic categories and criticism for representing an unscientific system that enshrines the opinions of a few powerful psychiatrists. Critics argue that the categories are broad, often specified by numerous possible combinations of symptoms, and that many of the categories overlap in symptomology or typically occur together. The process of labeling people has been shown to change how individuals experience themselves, as philosopher Ian Hacking observed with the case of multiple personality disorder, which exploded from double digits to an estimated six thousand cases between 1972 and 1986. The prevalence of autism in the United States has quadrupled over the past twenty years, a major driver of which has been a broadening of the definition and a lowering of the diagnostic threshold. In 2022, a major review identified the chemical imbalance theory used to market psychiatric drugs for decades as empirically unsubstantiated, leading to accusations of systemic pharmaceutical marketing fraud. The scientific validity of psychiatric diagnosis continues to be challenged due to the lack of objective biological pathology, such as tissue damage or biomarkers, leaving the field to rely on consensus rather than objective laboratory measures.
The Anti-Psychiatry Movement and Ethical Controversies
The term anti-psychiatry was coined by psychiatrist David Cooper in 1967 and was later made popular by Thomas Szasz, who characterized the field as a pseudoscience or a form of social control masquerading as medicine. The basic premise of the movement is that psychiatrists attempt to classify normal people as deviant, and that psychiatric treatments are ultimately more damaging than helpful to patients. The movement highlights the dangerous treatments of the past, such as psychosurgery, and the ongoing use of coercion and the influence of the pharmaceutical industry. Discredited psychiatrists who operated outside the norms of medical ethics include Harry Bailey, Donald Ewen Cameron, Samuel A. Cartwright, Henry Cotton, and Andrei Snezhnevsky. The World Psychiatric Association issued an ethical code to govern the conduct of psychiatrists, first set forth through the Declaration of Hawaii in 1977, but the profession has continued to face criticism for its historical role in social control and contentious treatments. The chemical imbalance theory, used to market psychiatric drugs for decades, was recently identified as empirically unsubstantiated by a major 2022 review, leading to accusations of systemic pharmaceutical marketing fraud. Furthermore, the paradigm of chronic pharmaceutical maintenance has been challenged by longitudinal studies, such as the 20-year Chicago Follow-up Study, which found that patients diagnosed with schizophrenia who discontinued antipsychotic medication achieved significantly higher rates of functional recovery and employment compared to those who remained medicated.
Deinstitutionalization and the Community Care Paradox
In 1963, US president John F. Kennedy introduced legislation delegating the National Institute of Mental Health to administer Community Mental Health Centers for those being discharged from state psychiatric hospitals. The intention was to provide care for the chronically mentally ill, but the focus of the centers shifted to providing psychotherapy for those with acute but less serious mental disorders. Ultimately, there were no arrangements made for actively following and treating severely mentally ill patients who were being discharged from hospitals, resulting in a large population of chronically homeless people with mental illness. This trend, known as deinstitutionalization, saw the average inpatient psychiatric treatment stay decrease significantly since the 1960s, with people receiving psychiatric treatment more likely to be seen as outpatients. However, the reduction in psychiatric beds since the mid 20th century has left many facilities in developing countries grossly inadequate, and even in developed countries, programs in public hospitals vary widely. Some may offer structured activities and therapies offered from many perspectives, while others may only have the funding for medicating and monitoring patients. Italy has been a pioneer in psychiatric reform, particularly through the no-restraint initiative that began nearly fifty years ago, influenced by Franco Basaglia. A study examining the application of these principles in Italy found that 14 general hospital psychiatric units reported zero restraint incidents in 2022. Yet, the promise of community care has often failed to deliver the necessary support, leaving many patients without the resources they need to survive outside the hospital walls.
The Future of Diagnosis and Treatment
Psychiatric research is, by its very nature, interdisciplinary, combining social, biological and psychological perspectives in attempt to understand the nature and treatment of mental disorders. Under the supervision of institutional review boards, psychiatric clinical researchers look at topics such as neuroimaging, genetics, and psychopharmacology in order to enhance diagnostic validity and reliability, to discover new treatment methods, and to classify new mental disorders. In 2018, the American Psychological Association commissioned a review to reach a consensus on whether modern clinical MRI/fMRI will be able to be used in the diagnosis of mental health disorders. The criteria presented by the APA stated that the biomarkers used in diagnosis should have a sensitivity of at least 80% for detecting a particular psychiatric disorder and a specificity of at least 80% for distinguishing this disorder from other psychiatric or medical disorders. The review concluded that although neuroimaging diagnosis may technically be feasible, very large studies are needed to evaluate specific biomarkers which were not available. The field continues to grapple with the lack of objective biological markers, with some clinicians beginning to utilize genetics and automated speech assessment during the diagnostic process, but on the whole these remain research topics. The future of psychiatry may lie in the integration of these new technologies with the traditional methods of psychotherapy and psychopharmacology, creating a more comprehensive approach to mental health that addresses both the biological and the social dimensions of mental illness.